Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000462160 | SCV000541364 | pathogenic | Nephronophthisis | 2022-07-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 30779). This premature translational stop signal has been observed in individuals with Leber congenital amaurosis (PMID: 21220633, 27624628). This variant is present in population databases (rs387907009, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Glu346*) in the IQCB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IQCB1 are known to be pathogenic (PMID: 15723066, 21901789, 23559409, 28041643). |
Ocular Genomics Institute, |
RCV000023758 | SCV001573405 | pathogenic | Senior-Loken syndrome 5 | 2021-04-08 | criteria provided, single submitter | research | The IQCB1 c.1036G>T variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2, PM3, PP1-M, PS3. Based on this evidence we have classified this variant as Pathogenic. |
Fulgent Genetics, |
RCV000023758 | SCV002788089 | pathogenic | Senior-Loken syndrome 5 | 2021-11-13 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000023758 | SCV004192432 | pathogenic | Senior-Loken syndrome 5 | 2024-03-04 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000023758 | SCV000045049 | pathogenic | Senior-Loken syndrome 5 | 2011-01-01 | no assertion criteria provided | literature only | |
NIHR Bioresource Rare Diseases, |
RCV000504719 | SCV000598849 | pathogenic | Leber congenital amaurosis | 2015-01-01 | no assertion criteria provided | research |